POSTERIOR CHAMBER IOL'S

Intraocular Lens

FDA Premarket Approval P970034 S009

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for ophthalmic innovations international, inc. To private-label its pma-approved posterior-chamber intraocular lenses for distribution in the united states by ciba vision corporation. The devices as modified will be marketed under the trade-names, ciba vision intraocular lens models 0420f, 0455f, 0440u, 0840u, 0430m, 0840z2, and 0840z, and are indicated for the visual correction of aphakia in persons 60 years of age or older, who are undergoing extracapsular extraction and primary lens implantation.

DevicePOSTERIOR CHAMBER IOL'S
Classification NameIntraocular Lens
Generic NameIntraocular Lens
ApplicantAAREN SCIENTIFIC
Date Received2001-04-19
Decision Date2001-06-29
PMAP970034
SupplementS009
Product CodeHQL
Advisory CommitteeOphthalmic
Supplement TypeNormal 180 Day Track
Supplement ReasonOther Report
Expedited ReviewNo
Combination Product No
Applicant Address AAREN SCIENTIFIC 4290 East Brickell St, Bldg A ontario, CA 91761

Supplemental Filings

Supplement NumberDateSupplement Type
P970034Original Filing
S014 2009-10-28 135 Review Track For 30-day Notice
S013
S012 2008-08-13 30-day Notice
S011 2008-08-13 30-day Notice
S010 2007-12-20 135 Review Track For 30-day Notice
S009 2001-04-19 Normal 180 Day Track
S008 2001-03-26 Normal 180 Day Track
S007 2000-07-06 Normal 180 Day Track
S006 2000-04-19 Normal 180 Day Track
S005 2000-02-14 Normal 180 Day Track
S004 2000-02-14 Panel Track
S003 1999-03-23 30-day Notice
S002 1998-12-21 Normal 180 Day Track
S001 1998-10-22 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.